Skip to content
Semawise
Menu

Provider review

Peter MD review

The cheaper-looking monthly tier is not actually the cheaper total.

Its own numbers show the lower per-month rate for returning patients adds up to more than the higher per-month rate for new patients, over a similar supply window.

Price, exactly as they publish it

Compounded semaglutide (marketed as "GLP1 + B12") is $149/month for first-time patients ($447 total for an estimated 10-12 week supply) and $139/month for returning patients ($834 total for an estimated 8-12 week supply). Also offered: tirzepatide at $149 the first month then $249/month, sermorelin around $195-211/month, NAD+ at $369 for an 8-10 week supply, and TRT at $79/month. Not available in several states, including AL and ID

Check Peter MD pricing

Semaglutide is prescription-only and compounded semaglutide is not the FDA-approved brand product — decide with a clinician. Prices are as the provider published them when we last checked; confirm current terms before you buy.

How Semawise makes money (plainly)

Here's the honest version: some of the links on this site are affiliate links, routed through the Katalys network. Click one and go on to start a treatment or buy something, and we may earn a commission — without costing you a single penny more. That's what keeps the lights on and the answers free. The part that matters: a commission never buys a softer review, a different price, or kinder pros and cons. What it does buy is position — affiliate partners are listed ahead of providers we have no relationship with, and we say so on each board rather than only here. Want the longer version? It's all in our full disclosure.

The verdict

Peter MD is a physician-prescribed telehealth brand that has been operating since 2021, selling compounded semaglutide (marketed as a GLP1-plus-B12 formulation) alongside a genuinely wide menu — tirzepatide, sermorelin, NAD+ and TRT — all under one account. Pricing lands in two tiers, one for first-time patients and one for returning ones, and the tier with the lower monthly figure is the one with the higher total cost over a comparable supply window — exactly the kind of headline-versus-total gap worth doing the arithmetic on before you commit rather than after. It also excludes a handful of states outright, and neither a compounding pharmacy nor a facility class is named anywhere on its public pages.

The trade-off we'd want you to read first

Priced in two tiers by first-time-vs-returning status rather than one flat figure — and the lower $139/mo returning tier totals $834 against the first-time tier's $447, a HIGHER total despite the lower monthly number

Who it suits, and who it doesn't

A good fit if

  • You want one telehealth account that can also fill tirzepatide, sermorelin, NAD+ or TRT later without switching providers
  • You are comfortable working out the total cost yourself rather than taking the lower-looking monthly tier at face value

Look elsewhere if

  • You live in one of the several states this program excludes and have not confirmed your own state first
  • You want a single flat monthly number rather than a two-tier structure where the lower-looking figure is not the lower total

How the programme actually works

Peter MD is a physician-prescribed telehealth brand headquartered in Miami, FL, operating since 2021. Its compounded semaglutide is sold under the name "GLP1 + B12" (semaglutide compounded with B12) on a two-tier structure: $149/month for first-time patients and $139/month for returning patients, each covering a several-week supply at a different total cost. Beyond semaglutide it runs a genuinely broad menu under one account — compounded tirzepatide, sermorelin, NAD+ and TRT — so a patient who wants to add or switch treatments does not need a second provider. The marketing page states plainly that the program is not available in AL, ID, AK or HI; the underlying affiliate program's own state-exclusion data separately confirms AL and ID for semaglutide specifically. Neither a compounding pharmacy name nor a facility class appears on the public pages, and customer reviews are mixed.

At a glance

Pricing structure
Varies by dose, plan or tier
Consult
Included in the price
Compounding pharmacy
Not publicly identified
Labs
Optional
Dietitian support
Not included

Source and full evidence quote in our Provenance Register.

What it does well

  • Physician-prescribed telehealth model with an operating history back to 2021
  • Broad menu beyond semaglutide alone — tirzepatide, sermorelin, NAD+ and TRT are all offered under the same account
  • Both pricing tiers are posted publicly on the product page rather than held behind a quiz

The other trade-offs

  • Not available in several states, including AL and ID — the marketing page also excludes AK and HI, and the underlying affiliate program separately excludes AL/ID for semaglutide and a wider state list for B-12 and tirzepatide
  • No pharmacy name, facility class, or certificate-of-analysis statement appears anywhere on Peter MD's public product pages
  • Customer reviews are mixed

If this one isn't it

If Peter MD is not it, these are not our favourites and they are not the ones that pay the most — each is the provider closest to this one that does better on the axis this one does worst on. The axis is named on every card, with both providers’ own published wording underneath, so you can check the claim rather than take it.

Any link on this page may earn us a commission if you go on to start care, at no extra cost to you — see our full disclosure. The cards above are chosen by the rule stated at the top of this section, which is computed from published figures and has no access to which providers pay us.

Before you buy

Semaglutide is a prescription medicine, and the compounded version is not the same regulated product as brand-name Wegovy or Ozempic. Whatever you decide, decide it with a clinician who knows your history — and go into that conversation with real numbers.

Where this sits on the board

Peter MD is one of 43 telehealth semaglutide programmes we track. The board puts every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to, rather than only in the small print.

Check Peter MD pricingCompare all 43 providers →

Semaglutide is prescription-only and compounded semaglutide is not the FDA-approved brand product — decide with a clinician. Prices are as the provider published them when we last checked; confirm current terms before you buy.